Hypoxia activates the hypoxia-inducible factor-1α/vascular endothelial growth factor pathway in a prostatic stromal cell line: A mechanism for the pathogenesis of benign prostatic hyperplasia

被引:0
作者
Zhang, Tao [1 ]
Mao, Changlin [2 ]
Chang, Yao [1 ]
Lyu, Jiaju [1 ]
Zhao, Delong [1 ]
Ding, Sentai [1 ]
机构
[1] Shandong First Med Univ, Shandong Prov Hosp, Dept Urol, Jinan 250021, Peoples R China
[2] Fujian Med Univ, Dept Urol, Mindong Hosp, Fuan, Peoples R China
关键词
Benign prostatic hyperplasia; Hypoxia-inducible factor-1 alpha; Vascular endothelial growth factor; Pathogenesis; miR-17-5p; FACTOR VEGF; HIF-1-ALPHA; EXPRESSION; MARKERS;
D O I
10.1097/CU9.0000000000000233
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe development of benign prostatic hyperplasia (BPH) is closely related to hypoxia in the prostatic stroma, and the hypoxia-inducible factor-1 alpha/vascular endothelial growth factor (HIF-1 alpha/VEGF) pathway has been shown to significantly activate in response to hypoxia. The underlying mechanism for activation of this pathway in the pathogenesis of BPH remains unclear.Materials and methodsWe constructed HIF-1 alpha overexpression and knockdown BPH stromal (WPMY-1) and epithelial (BPH-1) cell lines, which were cultured under different oxygen conditions (hypoxia, normoxia, and hypoxia + HIF-1 alpha inhibitor). Quantitative real-time polymerase chain reaction (qPCR) and Western blotting were applied to detect the expression of the HIF-1 alpha/VEGF pathway. Cell proliferation and apoptosis were analyzed by Cell Counting Kit-8 and flow cytometry. We used the miRWalk 2.0 database and Western blotting to predict the potential miRNA that selectively targets the HIF-1 alpha/VEGF pathway, and verified the prediction by qPCR and dual-luciferase assays.ResultsIn a BPH stromal cell line (WPMY-1), the expression of VEGF was in accordance with HIF-1 alpha levels, elevated in the overexpression cells and decreased in the knockdown cells. Hypoxia-induced HIF-1 alpha overexpression, which could be reversed by a HIF-1 alpha inhibitor. Moreover, the HIF-1 alpha inhibitor significantly depressed cellular proliferation and promoted apoptosis in hypoxic conditions, assessed by Cell Counting Kit-8 and flow cytometry. However, in the BPH epithelial cell line (BPH-1), the expression level of HIF-1 alpha did not influence the expression of VEGF. Finally, a potential miRNA, miR-17-5p, regulating the HIF-1 alpha/VEGF pathway was predicted from the miRWalk 2.0 database and Western blotting, and verified by qPCR and dual-luciferase assay.ConclusionsIn hypoxia, activation of the HIF-1 alpha/VEGF pathway plays a crucial role in regulating cell proliferation in a BPH stromal cell line. Regulation by miR-17-5p may be the potential mechanism for the activation of this pathway. Regulation of this pathway may be involved in the pathogenesis of BPH.
引用
收藏
页码:185 / 193
页数:9
相关论文
共 38 条
  • [1] Regulation of soluble VEGFR-2 secreted by microvascular endothelial cells derived from human BPH
    Aweimer, A.
    Stachon, T.
    Tannapfel, A.
    Koeller, M.
    Truss, M. C.
    Stachon, A.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (02) : 157 - 164
  • [2] Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF)
    Barratt, Shaney L.
    Blythe, Thomas
    Ourradi, Khadija
    Jarrett, Caroline
    Welsh, Gavin I.
    Bates, David O.
    Millar, Ann B.
    [J]. RESPIRATORY RESEARCH, 2018, 19
  • [3] Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia
    Berger, AP
    Kofler, K
    Bektic, J
    Rogatsch, H
    Steiner, H
    Bartsch, G
    Klocker, H
    [J]. PROSTATE, 2003, 57 (01) : 57 - 65
  • [4] Mesenchymal stem cells and the embryonic reawakening theory of BPH
    Brennen, W. Nathaniel
    Isaacs, John T.
    [J]. NATURE REVIEWS UROLOGY, 2018, 15 (11) : 703 - 715
  • [5] Correlations Among Cardiovascular Risk Factors, Prostate Blood Flow, and Prostate Volume in Patients With Clinical Benign Prostatic Hyperplasia
    Chen, I-Hung
    Tsai, Yuh-Shyan
    Tong, Yat-Ching
    [J]. UROLOGY, 2012, 79 (02) : 409 - 414
  • [6] Differential impact of paired patient-derived BPH and normal adjacent stromal cells on benign prostatic epithelial cell growth in 3D culture
    Chen, Wei
    Pascal, Laura E.
    Wang, Ke
    Dhir, Rajiv
    Sims, Alexa M.
    Campbell, Robert
    Gasper, Gwenyth
    DeFranco, Donald B.
    Yoshimura, Naoki
    Wang, Zhou
    [J]. PROSTATE, 2020, 80 (14) : 1177 - 1187
  • [7] Chen YB, 2019, INT J CLIN EXP PATHO, V12, P295
  • [8] Benign prostatic hyperplasia - what do we know?
    Devlin, Conor M.
    Simms, Matthew S.
    Maitland, Norman J.
    [J]. BJU INTERNATIONAL, 2021, 127 (04) : 389 - 399
  • [9] The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms Prevalence and Incident Rates
    Egan, Kathryn Brigham
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2016, 43 (03) : 289 - +
  • [10] What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?
    Foo, Keong Tatt
    [J]. WORLD JOURNAL OF UROLOGY, 2019, 37 (07) : 1293 - 1296